Department of Surgery, Faculty of Medical & Health Sciences, The University of Auckland, Auckland, New Zealand.
Waikato Cardiothoracic Unit, Waikato Hospital, Hamilton, New Zealand.
Heart Lung Circ. 2021 Mar;30(3):414-418. doi: 10.1016/j.hlc.2020.05.115. Epub 2020 Jul 6.
Inflammatory markers, such as neutrophils and lymphocytes, for risk stratification of postoperative morbidity and mortality in patients with cardiovascular disease may provide benefit for patient selection for cardiac surgery. This study aimed to investigate the association between preoperative neutrophil to leucocyte ratio (NLR) after cardiac surgery.
A retrospective study from September 2014 to November 2017 undergoing cardiac surgery at Waikato Hospital was conducted. Preoperative haematological profiles, patient factors and primary and secondary endpoints were obtained. The primary endpoint was 30-day new postoperative atrial fibrillation requiring treatment, new neurological insult, readmission within 30 days and 30-day mortality. The secondary endpoint was long-term all cause mortality.
Of the 1,694 patients included in the study, 21% (356/1,694) of patients had new atrial fibrillation (AF), 3.0% (51/1,694) strokes, 10.6% (180/1,694) readmissions and 2.8% (47/1,694) deaths within 30 days were observed. Receiver operator curve (ROC) returned a cut-off value of NLR equal to or greater than 3.23 (high NLR) to be associated with greatest mortality. Subsequently, a high NLR was compared to the endpoints. High NLR was associated with higher postoperative (p<0.001) and discharge creatinine, longer ICU stay (p=0.012), prolonged intubation and ventilation (p<0.001), new neurological status (p=0.002) and increased risk of returning to theatre (p=0.009). After logistic regression, high NLR was associated with increased mortality (OR 3.36, p=0.001).
The interpretation and utilisation of readily available haematological markers can provide further risk stratification data to the surgeon when considering the postoperative cardiac surgery risks.
炎症标志物,如中性粒细胞和淋巴细胞,可能为心血管疾病患者术后发病率和死亡率的风险分层提供益处,有助于选择进行心脏手术的患者。本研究旨在探讨心脏手术后中性粒细胞与白细胞比值(NLR)与术后新发房颤、新发神经损伤、术后 30 天内再入院和术后 30 天内死亡率等主要和次要终点之间的关系。
对 2014 年 9 月至 2017 年 11 月在怀卡托医院接受心脏手术的患者进行回顾性研究。收集术前血液学特征、患者因素及主要和次要终点数据。主要终点为 30 天内新发房颤(需要治疗)、新发神经损伤、术后 30 天内再入院和 30 天内死亡率。次要终点为长期全因死亡率。
本研究共纳入 1694 例患者,其中 21%(356/1694)的患者发生新发房颤,3.0%(51/1694)发生脑卒中,10.6%(180/1694)再入院,2.8%(47/1694)在术后 30 天内死亡。受试者工作特征(ROC)曲线得出 NLR 等于或大于 3.23(高 NLR)的截断值与死亡率升高相关。随后,比较高 NLR 与各终点的关系。高 NLR 与术后(p<0.001)和出院时肌酐水平更高、ICU 住院时间延长(p=0.012)、插管和通气时间延长(p<0.001)、新发神经状态(p=0.002)和再次手术的风险增加(p=0.009)相关。多因素逻辑回归分析显示,高 NLR 与死亡率升高相关(OR 3.36,p=0.001)。
当外科医生考虑心脏手术后的风险时,易于获得的血液学标志物的解读和应用可为进一步提供风险分层数据。